Has Chrisanna Dobrowolski, MD received payments from drug or device companies?

Yes. Drug and device makers reported $9,762 in general payments to Chrisanna Dobrowolski, MD across 33 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Chrisanna Dobrowolski, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Chrisanna Dobrowolski, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Chrisanna Dobrowolski, MD

Rheumatology · Bronx, NYNPI 1639619729

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $6,225 of the $9,762 with a category attached, or 63.8%. Novartis accounts for 85.7% of it on its own, with 4 other manufacturers making up the rest. 2025 is the largest year on record at $8,539, more than ten times the $77 reported in 2023.

$9,762in general payments, 2019–2025

Across 33 payments — averaging $295.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Novartis$8K
E.r. Squibb & Sons, L.L.C.$682
AstraZeneca$522
GSK$172
Amgen$20

$129,164in research payments, 2019–2025

Across 1 payment — averaging $129,164 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

E.r. Squibb & Sons, L.L.C.$129K

What the payments were for

Consulting fees$6,22564%
Speaking & faculty fees$3263%
Travel & lodging$2,00221%
Food & beverage$1,20912%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Novartis	10	$8,367
E.r. Squibb & Sons, L.L.C.	3	$682
AstraZeneca	10	$522
GSK	9	$172
Amgen	1	$20

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

SAPHNELO$360

How this compares

$9,762 in reported general payments places this provider in the 70th percentile of 541 rheumatology providers in New York.

See all rheumatology providers in New York →

Medicare billing

Part B allowed, 2024

$29,502

Medicare patients

Services billed

363

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
StelaraUstekinumab	13	$303,371
Humira(Cf) PenAdalimumab	17	$151,486
Enbrel SureclickEtanercept	18	$126,367
Actemra ActpenTocilizumab	27	$95,209
Orencia ClickjectAbatacept	16	$84,141
Colchicine	174	$7,603
Hydroxychloroquine Sulfate	302	$6,429
Mycophenolate Mofetil	32	$5,951
MethotrexateMethotrexate Sodium	256	$4,750
Diclofenac Sodium	160	$4,420
Cevimeline Hcl	24	$3,355
Leflunomide	59	$2,989
Azathioprine	39	$1,498
Pilocarpine Hcl	43	$1,239
Prednisone	187	$1,214

Paid to pharmacies, not to this prescriber.

Other rheumatology in Bronx

Vinita PatelBronx$73K
Beverly JohnsonBronx$63K
Arlene TiengBronx$51K
Laurie GlimcherNew York$3.9M
Grace WrightNew York$3M
Kostas BotsoglouCheektowaga$2.6M
Sergio SchwartzmanNew York$2.5M
Allan GibofskyNew York$1.9M
Petros EfthimiouNew York$791K
Richard FurieNew Hyde Park$746K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →